← Back to Clinical Trials
Recruiting NCT06838572

NCT06838572 Effect of Remote Local Peripheral Nerve Cooling on Pain of Arterial Puncture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06838572
Status Recruiting
Phase
Sponsor The Second Affiliated Hospital of Chongqing Medical University
Condition Acute Pain
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-02-15
Primary Completion 2025-09-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Skin cooling to 20°CSkin cooling to 15°CSkin cooling to 8°C

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-02-15 with a primary completion date of 2025-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this project, volunteers will be recruited to cool the superficial skin of the axillary brachial plexus away from the puncture point, resulting in local peripheral nerve cooling, and observe its impact on the pain of arterial puncture.To explore the local peripheral nerve cooling treatment can produce controllable and reversible analgesic effect even if away from the wound, and provide a new nonpharmaceutical analgesic mode for clinical.

Eligibility Criteria

Inclusion Criteria: 1. 18 \~ 65 years old; 2. ASA I-II level; 3. Patients with perioperative invasive arterial blood pressure monitoring; 4. Right-handed; 5. Allen test was normal (palm color quickly turned red or returned to normal within 10 seconds after release of ulnar artery pressure); 6. Participate voluntarily and be able to understand and sign informed consent. Exclusion Criteria: 1. Patients with a history of musculoskeletal, vascular, neurological or psychiatric disorders; 2. Patients with a history of diabetes or other systemic diseases 3. Patients who used any analgesic medication within the month before and during the study; 4. Patients with a history of smoking, alcohol or drug addiction; 5. Paraesthesia, scar, redness, damage, rash, etc. exist in the skin of the patient in the test area; 6. Patients whose surgical area overlaps with the cooling treatment or puncture area; 7. Female subjects are menstruating.

Contact & Investigator

Central Contact

He Huang, ph.D

✉ huanghe@cqmu.edu.cn

📞 86+13708385559

Principal Investigator

He Huang, ph.D

STUDY CHAIR

The Second Affiliated Hospital, Chongqing Medical University

Frequently Asked Questions

Who can join the NCT06838572 clinical trial?

This trial is open to participants of all sexes, studying Acute Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06838572 currently recruiting?

Yes, NCT06838572 is actively recruiting participants. Contact the research team at huanghe@cqmu.edu.cn for enrollment information.

Where is the NCT06838572 trial being conducted?

This trial is being conducted at Chongqing, China.

Who is sponsoring the NCT06838572 clinical trial?

NCT06838572 is sponsored by The Second Affiliated Hospital of Chongqing Medical University. The principal investigator is He Huang, ph.D at The Second Affiliated Hospital, Chongqing Medical University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology